|
RELATED PARTY TRANSACTIONS
|
9 Months Ended | |
|---|---|---|
|
Sep. 30, 2013
|
||
| Related Party Transactions [Abstract] | ||
| Related Party Transactions Disclosure [Text Block] | 8. RELATED PARTY TRANSACTIONS
Jamey Weichert, the Company’s Chief Scientific Officer and principal founder of Cellectar, and a director and shareholder of the Company, is a faculty member at the University of Wisconsin-Madison (“UW”). During the three and nine months ended September 30, 2013, the Company made contributions to UW totaling $62,500 and $187,500, respectively for use towards unrestricted research activities. The Company paid $0 and $73,385 to UW for costs associated with clinical trial and other research agreements during the three and nine months ended September 30, 2013. The Company made contributions to UW of $62,500 and $206,500 for use towards unrestricted research activities during the three and nine months ended September 30, 2012, respectively, and paid UW $0 and $144,044 for costs associated with clinical trial agreements during the three and nine months ended September 30, 2012, respectively.
|